EGFR and lung cancer: Non-small cell lung cancer (NSCLC) is the major type of lung cancer, and around 14–38% of NSCLC patients harbor genetic alterations in epidermal growth factor receptor (EGFR) [2], with the incidence of EGFR mutations higher in East Asian patients than in Caucasian patients [3, 4].